Qualigen Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.8%.

Top 25 shareholders own 3.03% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0.66%	Geode Capital Management, LLC	41,895	US$11.9k	0%	no data
0.55%	Citadel Advisors LLC	34,779	US$9.9k	0%	no data
0.41%	BlackRock, Inc.	25,840	US$7.4k	0%	no data
0.36%	The Vanguard Group, Inc.	22,827	US$6.5k	0%	no data
0.33%	Michael Poirier	21,021	US$6.0k	0%	no data
0.19%	Northern Trust Global Investments	11,919	US$3.4k	0%	no data
0.17%	State Street Global Advisors, Inc.	10,930	US$3.1k	0%	no data
0.13%	Highmark Wealth Management LLC	8,009	US$2.3k	0%	no data
0.083%	Tower Research Capital LLC	5,260	US$1.5k	6.16%	no data
0.031%	Sidney Emery	1,968	US$560.7	0%	no data
0.029%	Kurt Kruger	1,800	US$512.9	0%	no data
0.02%	Christopher Lotz	1,254	US$357.2	0%	no data
0.013%	U.S. Bancorp Asset Management, Inc.	824	US$234.7	0%	no data
0.013%	Merrill Lynch & Co. Inc., Banking Investments	824	US$234.7	0%	no data
0.0067%	Group One Trading LP, Asset Management Arm	423	US$120.6	0%	no data
0.0064%	Ira Ritter	404	US$115.2	0%	no data
0.0061%	JPMorgan Chase & Co, Brokerage and Securities Investments	386	US$110.0	-0.26%	no data
0.0056%	The Retirement Group, LLC	350	US$99.7	0%	no data
0.0039%	ICA Group Wealth Management, LLC	245	US$69.7	0%	no data
0.0016%	UBS Asset Management AG	102	US$29.1	0%	no data
0.00062%	Wells Fargo & Company, Private Banking and Investment Banking Arm	39	US$11.1	5.41%	no data
0.00025%	Archer Investment Corporation	16	US$4.5	0%	no data
0.00016%	Bank of America Corporation, Asset Management Arm	10	US$2.9	0%	no data
0.00006%	City National Rochdale, LLC	4	US$1.1	0%	no data
0.00003%	Strategic Advisers LLC	2	US$0.5	0%	no data